1-1 of 1
Maximilian Fleischmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary pharmacokinetic and MRD results from AML patients treated with 7- and 14-day dosing schedule of emavusertib added to combination therapy with azacitidine and venetoclax

Free
Cristina Papayannidis, Ulf Schnetzke, Maximilian Fleischmann, Adolfo De La Fuente Burguera, Klaus Metzeler, Maureen Lane, Li Zhou, Ahmed Hamdy, Claudio Cerchione
Journal: Blood
Blood (2025) 146 (Supplement 1): 5201.
https://doi.org/10.1182/blood-2025-5201
Published: 2025